Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
1.095
-0.095 (-7.98%)
Mar 31, 2025, 2:35 PM EDT - Market open
Acumen Pharmaceuticals Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $66.33 million as of March 31, 2025. Its market cap has decreased by -73.67% in one year.
Market Cap
66.33M
Enterprise Value
-129.74M
1-Year Change
-73.67%
Ranking
Category
Stock Price
$1.10
Market Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $66.33M, a decrease of -89.27%. That is a compound annual growth rate of -44.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 72.08M | -30.25% |
| Dec 31, 2024 | 103.34M | -53.53% |
| Dec 29, 2023 | 222.38M | 0.62% |
| Dec 30, 2022 | 221.00M | -19.22% |
| Dec 31, 2021 | 273.58M | -55.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 723.03B |
| UnitedHealth Group | 479.49B |
| Johnson & Johnson | 400.42B |
| AbbVie | 370.19B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 229.03B |
| Merck & Co. | 224.68B |